U.S. flag

An official website of the United States government

NM_170707.4(LMNA):c.949G>A (p.Glu317Lys) AND not specified

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Sep 25, 2018
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001000784.8

Allele description [Variation Report for NM_170707.4(LMNA):c.949G>A (p.Glu317Lys)]

NM_170707.4(LMNA):c.949G>A (p.Glu317Lys)

Gene:
LMNA:lamin A/C [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1q22
Genomic location:
Preferred name:
NM_170707.4(LMNA):c.949G>A (p.Glu317Lys)
HGVS:
  • NC_000001.11:g.156135913G>A
  • NG_008692.2:g.58341G>A
  • NM_001257374.3:c.613G>A
  • NM_001282624.2:c.706G>A
  • NM_001282625.2:c.949G>A
  • NM_001282626.2:c.949G>A
  • NM_005572.4:c.949G>A
  • NM_170707.4:c.949G>AMANE SELECT
  • NM_170708.4:c.949G>A
  • NP_001244303.1:p.Glu205Lys
  • NP_001269553.1:p.Glu236Lys
  • NP_001269554.1:p.Glu317Lys
  • NP_001269555.1:p.Glu317Lys
  • NP_005563.1:p.Glu317Lys
  • NP_733821.1:p.Glu317Lys
  • NP_733822.1:p.Glu317Lys
  • LRG_254t2:c.949G>A
  • LRG_254:g.58341G>A
  • NC_000001.10:g.156105704G>A
  • NM_170707.2:c.949G>A
  • NM_170707.3:c.949G>A
  • P02545:p.Glu317Lys
  • c.949G>A
Protein change:
E205K
Links:
UniProtKB: P02545#VAR_039775; dbSNP: rs56816490
NCBI 1000 Genomes Browser:
rs56816490
Molecular consequence:
  • NM_001257374.3:c.613G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001282624.2:c.706G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001282625.2:c.949G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001282626.2:c.949G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_005572.4:c.949G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_170707.4:c.949G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_170708.4:c.949G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001157842ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
criteria provided, single submitter

(ARUP Molecular Germline Variant Investigation Process)
Likely pathogenic
(Sep 25, 2018)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories, SCV001157842.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The LMNA c.949G>A; p.Glu317Lys variant (rs56816490), is reported in the literature in multiple individuals and families affected with dilated cardiomyopathies (DCM) and atrioventricular block with DCM (Arbustini 2002, Millat 2009, Pasotti 2008, Villa 2014, Walsh 2017). This variant is reported as pathogenic/likely pathogenic by multiple laboratories in ClinVar (Variation ID: 48093) and is only observed on one allele in the Genome Aggregation Database, indicating it is not a common polymorphism. The glutamic acid at codon 317 is highly conserved, and computational analyses (SIFT, PolyPhen-2) predict that this variant is deleterious. Based on available information, the p.Glu317Lys variant is considered to be likely pathogenic. References: Arbustini E et al. Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related disease. J Am Coll Cardiol. 2002 Mar 20;39(6):981-90. Millat G et al. Validation of high-resolution DNA melting analysis for mutation scanning of the LMNA gene. Clin Biochem. 2009 Jun;42(9):892-8. Pasotti M et al. Long-term outcome and risk stratification in dilated cardiolaminopathies. J Am Coll Cardiol. 2008 Oct 7;52(15):1250-60. Villa F et al. A G613A missense in the Hutchinson's progeria lamin A/C gene causes a lone, autosomal dominant atrioventricular block. Immun Ageing. 2014 Nov 26;11(1):19. Walsh R et al. Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples. Genet Med. 2017 Feb;19(2):192-203.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 20, 2024